Biggest News Aggregation in the World
📰 Linkedin News

Page 497 - Linkedin News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Linkedin. Real-time updates on events, politics, business and more.

Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status

TOKYO and CAMBRIDGE, Mass., May 14, 2024 /PRNewswire/ -- Eisai Co., Ltd. and Biogen Inc. announced today that Eisai has initiated the rolling submission of a Biologics License Application to the...
South Korea United Kingdom United States Saudi Arabia Hong Kong Great Britain

Bausch Health Announces Updates Related to Norwich XIFAXAN Matters

LAVAL, QC / ACCESSWIRE / May 14, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology business Salix Pharmaceuticals, today announced certain updates related to its litigation with Norwich Pharmaceuticals, Inc.With respect to the April 11, 2024, decision of the US Court of Appeals for the...
New Jersey United States Garen Sarafian Kevin Wiggins Norwich Pharmaceuticals Inc Exchange Commission

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Globe Life Inc. f/k/a Torchmark Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – GL - Globe Life (NYSE:GL)

NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Globe Life Inc. f/k/a Torchmark Corporation (NYSE:GL) between May 8, 2019 and
United States New York Laurence Rosen Phillip Kim American Income Life Insurance Company Torchmark Corporation

NANOBIOTIX Announces US FDA Protocol Acceptance for New Randomized Phase 2 Study Evaluating ...

PARIS and CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering nanoparticle-based therapeutic approaches to expand
New York United States France General United Kingdom Louis Kayitalire Johnson Enterprise Innovation Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science